î
îŒ
ãã°ã€ã³
î
Molecular Partners AG
MOLN3.930USD
-0.123-3.02%
çµå€Â 03/30, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
146.98Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± Molecular Partners AG äŒæ¥å
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AGã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãMOLN
äŒç€ŸåMolecular Partners AG
äžå Žæ¥Oct 22, 2014
æé«çµå¶è²¬ä»»è
ãCEOãAmstutz (Patrick)
åŸæ¥å¡æ°159
蚌åžçš®é¡Depository Receipt
決ç®ææ«Oct 22
æ¬ç€Ÿæåšå°Wagistrasse 14
éœåžSCHLIEREN
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœSwitzerland
éµäŸ¿çªå·8952
é»è©±çªå·41447557700
ãŠã§ããµã€ãhttps://www.molecularpartners.com/
äŒæ¥ã³ãŒãMOLN
äžå Žæ¥Oct 22, 2014
æé«çµå¶è²¬ä»»è
ãCEOãAmstutz (Patrick)
Molecular Partners AGã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Vasconcelles, M.D.
Dr. Michael Vasconcelles, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
åçå èš³
é貚: USDæŽæ°æå»: Tue, Jan 6
é貚: USDæŽæ°æå»: Tue, Jan 6
FY2025Q3
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
Switzerland
0.00
0.00%
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Fri, Feb 13
æŽæ°æå»: Fri, Feb 13
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
SmartHarvest Portfolios, LLC
0.03%
ä»ã®
90.41%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Suvretta Capital Management, LLC
5.94%
BVF Partners L.P.
3.62%
SmartHarvest Portfolios, LLC
0.03%
ä»ã®
90.41%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Hedge Fund
9.56%
Investment Advisor
0.03%
ä»ã®
90.41%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Thu, Jan 1
æŽæ°æå»: Thu, Jan 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2025Q4
15
3.58M
9.57%
-32.52K
2025Q3
15
3.59M
9.59%
-23.51K
2025Q2
16
3.58M
9.72%
-44.38K
2025Q1
16
3.58M
9.72%
-44.38K
2024Q4
16
3.58M
10.80%
+1.75M
2024Q3
19
850.31K
2.56%
-138.97K
2024Q2
20
861.27K
2.60%
-213.87K
2024Q1
22
946.77K
2.88%
-611.83K
2023Q4
26
957.56K
2.63%
-624.65K
2023Q3
28
961.52K
2.93%
-686.56K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Suvretta Capital Management, LLC
2.22M
5.94%
--
--
Sep 30, 2025
BVF Partners L.P.
1.35M
3.62%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
1.07K
0%
--
--
Nov 30, 2025
Morgan Stanley & Co. LLC
367.00
0%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
5.34K
0.01%
-4.86K
-47.65%
Sep 30, 2025
EverSource Wealth Advisors, LLC
155.00
0%
+114.00
+278.05%
Sep 30, 2025
BofA Global Research (US)
157.00
0%
--
--
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
--
0%
-269.00
-100.00%
Jun 30, 2025
Qube Research & Technologies Ltd
--
0%
-16.00
-100.00%
Sep 30, 2024
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
